Basal and Bolus Insulin Dose Changes after Switching Basal Insulin to Insulin Degludec in Patients with Type 1 Diabetes Mellitus: A Pilot Study.

Yoshiyuki HamamotoSachiko HonjoKanta FujimotoShinsuke TokumotoHiroki IkedaYoshiharu WadaHiroyuki Koshiyama

Published in: Clinical drug investigation (2018)

DEG improved glycemic control when switched from once-daily BI and maintained glycemic control when switched from twice-daily BI without increasing hypoglycemia.

Keyphrases

glycemic control
type diabetes
blood glucose
weight loss
insulin resistance
physical activity
adipose tissue